Characteristics of the expanded group of controls and PMDD participants†.

†This table presents characteristics from the 5 control participants and 5 PMDD participants included in Table 1, but the control group is supplemented by demographics data from 3 other young healthy women who were studied under constant conditions in unrelated experiments. This larger group of 8 controls was compared to the 5 PMDD women of the current study during the FP in an attempt to increase sample size and further confirm results from our baseline group comparisons. Menstrual phase length, VAS-core scores, and progesterone and estradiol levels were not available for the 3 supplementary control participants. Values are mean ± SEM.